R&D Separating scientific risk assessment & consumer perception In pharmaceutical development, conclusions are built on structured laboratory investigations and reproducible data, rather than simple classification.
R&D Navigating development in a complex molecule world For decades, the pharmaceutical industry has relied on accelerated development and manufacturing timelines to bring new therapies to patients quickly.
R&D Saudi pharma’s rise as a global CDMO destination: Investment... Saudi Arabia is steadily establishing itself as a competitive worldwide destination for contract development and manufacturing.
Digital Sponsored Future proofing production: Implementing AI in pharmaceutica... Read Zühlke’s new white paper, ‘Future Proof Production: Implementing AI in pharmaceutical manufacturing’ today.
Market Access How manufacturing keeps pace with innovation in cell and gen... Cell and gene therapies are one of the most fast-moving and paradigm-shifting areas in pharmaceutical development today, bringing curative treatments to patients for the first time for cert
R&D Why Ireland has emerged as Europe’s biopharma hotspot Ireland is attracting major investment from the largest pharma companies in the world.
News Alzheimer's patients 'not changing brain health behaviours' Researchers have found that people with early Alzheimer's are not following guidelines for promoting brain health, even if they are on drug therapy.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.